been shown to be distinct from PTSD. 11, 12 Thus, EEG is a promising candidate for a biomarker of posttraumatic stress symptoms, but warrants further research. 14 The work reviewed above illustrates the potential for using resting-state EEG to help characterize posttrauma symptom presentations at the endophenotypic level. Including biologic validators may be particularly relevant for complicated polytrauma populations that often present with high rates of comorbidity (eg, PTSD and TBI), with phenotypic features that often overlap. Here, we aim to expand on work in this sample that identified distinct EEG profiles associated with PTSD and mTBI status 15 by examining the association of EEG profiles with PTSD symptom clusters. More specifically, Franke et al 15 found both chronic mTBI and PTSD were associated with changes in the EEG power profile, particularly in the low frequencies (delta and theta), but in opposing and spatially distinct patterns. In univariate analyses, mTBI was significantly associated with increased delta and theta power; conversely, PTSD status was associated with decreased delta and theta power. These findings align with work that has linked increases in delta and theta activity to reduced arousal states (ie, what would be seen in TBI 16 ). The decreases in low frequency power associated with PTSD were posited to reflect increased arousal or vigilance, which could be further examined by specifically testing the association with specific symptom clusters. Furthermore, the authors noted that while differences in low frequencies will be useful in clinical applications and efforts to differentiate conditions using EEG, given the common comorbidity of PTSD and mTBI and the fact that the widespread oppositional effect of this comorbidity could "cancel out" EEG effects, further differentiation is needed.
As such, we sought to expand on earlier findings of altered power in low frequency bands as a function of mTBI and PTSD in a polytrauma sample by examining the effects of PTSD symptoms separate from mTBI effects. The aim of the present study was to test the association of latent EEG resting-state power to specific PTSD symptom factors, after removing the effects of mTBI on EEG power bands. Data were analyzed in a structural equation framework, as compared with individual power bands in the previous work. Models examined the delta and theta bands, to compare with previous work, as well as alpha and beta bands given the extant associations with PTSD in previous studies. We hypothesized that with mTBI effects removed, PTSD symptoms would be (a) inversely associated with EEG activity and (b) EEG power profiles would be differentially associated across the PTSD symptom factors. More tentatively, given the association of reduced activity in low-frequency bands with arousal or vigilance, we hypothesized that decreased activity in the delta and theta frequency band factors would be associated with the hyperarousal symptom factor.
Methods

Participants
Participants were recruited from several local military bases and polytrauma clinics at a local VA medical center. Participants were sampled from a large epidemiological study of the effects of blast exposure during OEF/OIF conflicts. 17 To be eligible for the parent study, participants had to be active-duty service members or Veterans who had been exposed to at least one blast event during deployment within the 2 years prior to enrollment (an average of 10.9 months [SD = 13.2] since "worst" blast exposure). The parent study specifically sought only blast events that were potentially concussive, therefore the investigators required participants to have experienced any of the following symptoms/consequences during or shortly after the blast/explosion event: feeling dazed, confused, saw stars, headache, dizziness, irritability, memory gap, hearing loss, abdominal pain, shortness of breath, struck by debris, knocked over or down, knocked into/against something, helmet damaged, or evacuated. Participants were excluded if they had ever experienced a moderate or severe TBI (defined as >30 minutes in a coma, having a traumatic abnormality on brain computed tomography scan, or posttraumatic amnesia of >24-hour duration).
Because of the epidemiologic nature of the overarching study, there were no psychiatric-related exclusionary criteria available for consideration. Participants were, however, administered the Mini-International Neuropsychiatric Interview (MINI 18 ), a short, structured diagnostic interview. Current psychiatric diagnoses were minimal (depression, 8.8%, n = 13; mania/hypomania, 6.8%, n = 10; current panic disorder, 8.2%, n = 12; social phobia, 5.4%, n = 8; obsessive compulsive disorder, 4.8%, n = 7; specific phobia, 3.4%, n = 5) with 21.8% (n = 32) having at least on additional psychiatric diagnosis. Participants were also not excluded based on history of psychotropic medication use, but this information was collected for analyses. It was previously demonstrated that a majority of individuals (76%) were not on any medication and psychotropic medication use did not vary across mTBI or PTSD; medication information is presented in detail elsewhere. 15 A total of 147 participants who completed EEG testing with clean data collected during the target state of relaxed wakefulness comprised the final sample for analyses. This sample was primarily male (96%) and Caucasian (72.8%) with an average age of 27.8 years (SD = 7.9). EEG Collection and Processing. EEG activity was recorded from 19 electrode sites based on the 10-20 configuration using the Mitsar 201 amplifier system (Mitsar Medical, St Petersburg, Russia) at a sampling rate of 500 Hz. Impedances for all recordings were verified to be less than 5 kohm. Following the recording, EEGs were re-referenced to averaged mastoid electrodes and Butterworth filters (fifth order, passband of 1-40 Hz) were applied to all EEG recordings. They were then reviewed for movement or electrical artifact by participant-blinded evaluators, and segments containing artifacts were removed. EEG epochs of 4 seconds (overlapping 50%) were smoothed via Hanning time window and spectral information was computed by a fast Fourier transform (Neuroguide; Applied Neuroscience, Inc). Prior to data analysis, EEGs that were found to be contaminated by excessive noise in the reference channels were excluded, as were those determined to have been recorded during a sleep state, resulting in a final sample of n = 147 from an original sample of n = 176 (28 cases removed for the reasons stated, remaining case removed due to file error). Excluded participants did not differ from those retained based on age, time since injury, or rates of mTBI or PTSD (all Ps >.05).
Procedures
Creation of EEG Variables. Absolute power in 4 frequency bands was computed (delta, 1-4 Hz; theta, 4-8 Hz; alpha, 8-12 Hz; and beta, 12-25 Hz) to create power profiles at 10 spatially distributed cerebral electrode sites. Log transformations were applied to the EEG power variable values due to skewness. . These indicators were selected based on previously observed associations between these bands and PTSD in existing literature and this sample. 11, 15 See Supplemental Table 1 (available in the online version of the article) for EEG power across frequency bands at the 4 regions of interest. The EEG factors for alpha, beta, delta, and theta frequency bands were included as exogenous variables in the model to test for differential prediction of variation across the four PTSD symptom factors (described below).
Statistical Analyses
Determination of Posttraumatic Stress Symptom Factor Structure. Although a number of different factor structures have been reported for the PCL, our modeling followed previous literature, 22 which found evidence of a 4-factor model in a polytrauma Veteran sample consistent with the 4-factor numbing model (re-experiencing, avoidance, numbing, hyperarousal). 23 Nonetheless, confirmatory factor analysis models were fit to the 17 items for 1, 3, and 4 factor structures. Item level responses were treated as ordinal variables with 5 ordered categories that yielded 5 thresholds per item. Analyses were performed using the Mplus 7.11 software 24 using the weighted least squares mean and variance adjusted robust estimator to optimize model fit and obtain parameter estimates and standard errors.
Structural Equation Modeling
. The log transformed EEG power variables were converted to ordinal variables for use in the subsequent structural equation model analyses. Based on findings of an oppositional effect of mTBI and PTSD in previous work in this sample 15 and our interest in using EEG power as a predictor of the PTSD symptom factors, the EEG common factor was regressed onto the mTBI binary status variable creating a residual factor with the group mean mTBI difference effect removed. Then, the 4 oblique PTSD symptom common factors were regressed onto the EEG residual factor to investigate whether there were differential EEG effects. Separate models were fit for the alpha, beta, delta, and theta EEG band factors, using regional averages for each frequency band as factor indicators.
An unrestricted reference baseline model was fit with all 4 paths from the residual EEG power factor to the 4 symptom factors freely estimated. Given power limitations due to sample size, covariates were not included in the models. A theoretical path diagram of this model is presented in Figure 1 . For each of the separate external EEG → symptom factor validations, several restrictive nested comparison models were then fit. Nested model testing is an alternative way of evaluating differences in the external EEG path estimates compared with the more standard practice of reporting statistical significance P values for each point estimate. This approach provides a more demanding test in that global model misfit for the compared nested models is being evaluated within the context of the full measurement and structural model specification. To estimate a residual EEG factor, one of the indicators of the EEG factor was fixed to 1 to satisfy the necessary identification requirement. Within each of the EEG frequency band prediction models, the 4 symptom factors were regressed onto this common residual factor to test for possible differential effect sizes.
The model comparisons were conducted in the same order for each frequency band. An initial, unconstrained model where all paths were freely estimated was fit. Then, in a constrained model, all paths from the residual EEG factor to the symptom factors were fixed to zero and compared with the unrestricted baseline model as a joint global test of the EEG prediction values for the 4 symptom factors. Next, all 4 predictor regression paths were forced to be equal, testing the hypothesis that there are no differences in the EEG factor prediction effect sizes on the 4 different symptom factors. Each of the EEG-directed paths from the EEG factor to the symptom factors were then individually dropped by fixing their path coefficient to zero to test which symptom factors are needed for the model. Finally, as an additional test of the differential EEG-symptom factor relationships, the avoidance and numbing factor effects were set to zero. In combination, these restrictive models and their comparison tests serve as a more powerful way to determine if and which symptom factors are differentially predicted by the EEG factors.
Results
Posttraumatic Stress Symptom Factor Structure
Confirmatory factor analyses of the PCL found that the 4-factor model provided a better overall fit, χ 2 (113) = 236.87, P < .001, with comparative fit index (CFI), Tucker-Lewis index (TLI), and root mean square error of approximation (RMSEA) in the acceptable range (.967, .961, and .086, respectively) using conventional cutoff recommendations (eg, CFI and TLI values >.95 considered relatively good model fits; RMSEA <.05 indicates good fit, <.08 indicates reasonable fit). Information on confirmatory factor analysis model fitting, omnibus fit statistics for each model and standardized factor loadings and correlations are available in Supplemental Tables 2 and 3 .
EEG Power Predicting Posttraumatic Stress Symptom Factors
The regression of the EEG power common factor onto the mTBI binary variable provides a test of the mean difference between the mTBI groups. A positive coefficient indicates that individuals with mTBI (coded 1) have, on average, a higher overall EEG power compared with those without (coded 0). Removing the mTBI mean difference on the EEG factor, the residual EEG factor was then used in the structural equation models to predict the 4 symptom factors (illustrated in Figure 1) . For the unrestricted model, the residual EEG parameter path estimates of the power factors examined are presented in Table  1 . As hypothesized, standardized path coefficients were negative in valence for all 4 EEG factors predicting each of the 4 symptom factors. However, only the delta and theta effects for the avoidance (−0.193, standard error [SE] = 0.089, P = .03; −0.244, SE = 0.086, P = .005, respectively) and numbing (−0.242, SE = 0.078, P = .002; −0.240, SE = 0.085, P = .005, respectively) symptom factors were statistically different from zero (see Table 1 ). One exception was the positive path coefficient for beta predicting numbing. This, however, should be interpreted with caution as it was only significant in the multivariate test of "all equal" (ie, when EEG factor prediction effects on the four symptom factors were not differentiated), but all other multivariate and individual tests were nonsignificant (see Table 2 ). It is important to note that these EEG factor Note: µRF, µLF, µRO, µLO = localized EEG factor scores with the corresponding error terms; EEG = latent EEG factor from the four localized factors; EEGR = residual latent EEG factor; TBI = 0/1 mTBI status; v1-v17 = 17 PCL item scores; r1-r17 = error terms for 17 PCL items; Re-exp = re-experiencing symptom factor; Avoid = avoidance symptom factor; Numb = numbing symptom factor; HyperA = Hyperarousal symptom factor.
linear regressions are estimated in a model that allows the symptom factors to be intercorrelated (see Figure 1) . These EEG parameters were further examined using nested model comparisons to evaluate the predictive power distinguishing the avoidance and numbing factors from the re-experiencing and hypervigilance factors. Model comparisons are presented in Table 2 . Significant P values for these constrained model fits indicate the avoidance and numbing factors are significantly predicted by the EEG common factors for the delta and theta bands whereas this is not the case for the re-experiencing and hyper-arousal factors. In the final model that set both avoidance and numbing factor effects to zero, this model test again confirmed these factor effects cannot be dropped without significantly degrading overall model fit.
Discussion
The goal of this study was to extend on previous findings in this sample of blast-exposed active-duty service members or Veterans 15 of altered power in low-frequency bands as a function of PTSD status by examining whether there were differential associations of EEG power bands across the separate PTSD symptom factors. Given previous findings of altered power in opposing directions (ie, increased EEG power associated with mTBI and decreased EEG power associated with PTSD), we quantified the effects of mTBI on the resting state EEG profile and removed the effect, resulting in a residual EEG factor with the variance accounted for by mTBI removed. Then, given the heterogeneity of PTSD symptom clusters and their potential to have different biological signatures, we investigated the association of this exogenous indicator on the 4 symptom factors derived from the factor analysis of the PCL.
Present study findings were consistent with those reported by Franke et al 15 in this sample, using a different framework (eg, common factor of averaged locations as compared with individual site recordings) and expand on this work from PTSD status to specific PTSD symptom factors. As hypothesized, there was an inverse association between EEG factors (delta and theta bands) and PTSD symptom factors. In partial support of study hypotheses, delta and theta EEG power profiles, but not alpha or beta, significantly predicted some PTSD symptom factors (avoidance and numbing) but not others (re-experiencing and hyper activity). For illustrative purposes, Supplemental Figure 1 presents scatterplots of log transformed delta power at each region by symptom factor. The lack of association with the alpha power profile is in contrast to existing work that has demonstrated a positive association with alpha frequency and overall PTSD severity 25 and an inverse association with hyperarousal 26 although neither of these studies were of resting state. Findings add to the literature with regard to the lower frequency bands and further support that biological processes as assessed in EEG frequency bands can differentially predict symptom clusters. The specificity of EEG for particular PTSD symptoms was found even though these symptom factors are strongly correlated.
Given the strong correlations between the symptom factors (Supplemental Table 3 ), testing for differential effect sizes provides additional evidence that these symptom factors relate to the EEG exogenous factor with varying levels of strength. Using standardized EEG factors, negative regression path estimates indicated that a standard deviation increase in the common factor power scale corresponds to a linear negative beta decrease on the respective symptom factors. Specifically, higher EEG delta and theta power was associated with lower levels on the factors defined by avoidance and numbing symptoms; or, alternatively, lower delta and theta were associated with increased symptom severity of the avoidance and numbing factors. Decreased delta may indicate increased awareness, expected with increased PTSD severity. 27 Contrary to expectations and existing literature, 12 there was no association for any power bands with hyperarousal in this study. We had hypothesized an effect based on assumptions of hyperarousal being inversely associated with declining vigilance 8 but present findings suggest that declining vigilance may be more similar to avoidance and numbing instead. It also possible that this previous work was tapping into declining concentration, not vigilance. Alternatively, it may be that hyperarousal is more related to limbic and autonomic activity 28 and not dependent on cortical processes as measured by EEG. Regardless, findings suggest different frequency bands show symptom cluster specificity that warrants further investigation. Of relevance to the present findings is evidence of greater psychological pain associated with decreased resting-state delta power. 29 Speculatively, findings may indicate that, like psychological pain, avoidance and numbing symptoms resemble active aversive states. The external validity of emotional numbing as a construct has remained difficult to operationalize and assess. 30 Litz and Gray 31 have proposed that numbing may occur as a result of expending considerable effort to manage re-experiencing and hyperarousal symptoms which reduces emotional resources such as affective capacity. Present results are consistent with this view. Although substantitive interpretations of the suggestive association of increased beta and symtpoms (particularly numbing) in this study cannot be made given that the initial, primary model test was not significant, it is worth note that findings are in line with existing literature. For example, existing work has demonstrated increased beta activity associated with PTSD diagnosis, 32 and this result aligns with our other findings regarding numbing, especially if viewed as an active, vigilant process. Future work is needed to inform on the underlying process and functioning of avoidance and numbing symptoms.
Findings of a shared biological EEG signature for particular PTSD symptoms align with the growing trans-diagnostic approach of the Research Domains Criteria (RDoC) project. 33, 34 The present sample capitalizes on this potential by examining PTSD within combat-exposed Veterans with a range of PTSD values are reported for the WLSMV estimator, they should not be directly compared and interpreted. The adjusted P values for these robust χ 2 base tests can be consulted for inferential purposes. Model descriptions: All Free; Four EEG → PCL paths free; R = 0, only Re-experiencing path fixed to zero; A = 0, only Avoidance path fixed to zero; N = 0, only Numbing path fixed to zero; H = 0, only Hyperarousal path fixed to zero. Significant paths are in boldface. All restricted 1 degree of freedom nested tests compare a model with the particular EEG → PCL path fixed at zero against a model with all EEG paths free (ie, the All Free model). Boldface indicates significant estimates and significant models. symptom severity to investigate certain EEG patterns and profiles associated with PTSD symptom factors. In this study, we removed the effects of mTBI in order to specifically examine the association of EEG on PTSD symptom factors separate from mTBI. Linking physiological correlates with varying symptom presentations, if replicated, may suggest the value of external, biological indicators. Such indicators may assist in efforts to better understand and identify complicated symptom presentations, inform on differential diagnosis, and suggest treatment targets. This aligns with stated goals of RDoC for pathophysiology research to help provide a framework for classifying brain disorders based on empirical data. 33 The finding in Franke et al 15 of opposing EEG process in mTBI and PTSD suggests the need for a nuanced understanding of this process in comorbid populations. Continued work is important, particularly given mixed findings regarding the association of mTBI and increased risk for PTSD [35] [36] [37] and may help disentangle continued distress stemming from postconcussive syndrome after TBI versus PTSD.
Although some physiological measurements have shown diagnostic efficiency for PTSD, 38 despite continued growth, numerous challenges to the identification of valid and reliable biomarkers remain. 39 In the present study, the assessment of the EEG frequency bands is largely independent of self-referenced evaluative judgments of the individual participants whereas responses to the 17 PCL self-report items is clearly not. These 2 distinct sources of individual difference information have different inferential implications. While our analysis was done in conjunction with the PCL self-report information, it is a viable extension to relying solely on self-report modalities. This may be useful as reliance on introspection can have an impact on the accuracy of symptom reporting (ie, symptoms such as numbing and avoidance may themselves disrupt self-observation 39 ) and as such, the use of biomarkers can aid in diagnostic clarification.
Limitations and Future Directions
The findings presented should be considered within the context of limitations. First, because the sample size is considered small for structural equation modeling, other potentially important independent variables (eg, age, gender, medication use, handedness, depression symptoms) were not included in the models. Furthermore, the predominantly male sample affects generalizability of the findings. Thus, results should be considered preliminary pending additional work with larger samples. Future work with larger sample sizes, beyond providing needed replication, would also allow for consideration of other relevant symptoms, depression in particular given its association with PTSD, as well as evaluating alternative models (eg, bifactor models) that may better fit the data.
Second, PTSD symptom factors were examined within the full sample, regardless of PTSD diagnostic status. While this aligns with efforts to use a dimensional approach to identify biomarkers, further examination of whether this pattern would persist in a sample of individuals with diagnosed PTSD, and without mTBI is needed. The symptom factors were also highly intercorrelated. This may suggest a lack of clinical distinction between the factors or the presence of a second-order factor, yet the fact that EEG variables were able to differentially predict particular symptom factors suggests their distinctiveness and supports retaining the separate factor structure in such models. A related limitation is the lack of the updated PCL measure in which to better examine the 4 symptom clusters and additional items associated with DSM-5 and further examination is needed to determine whether this pattern would hold or if these symptom clusters would further distinguish themselves.
Finally, psychoactive medication is a potential contributor to EEG findings. 40 While it was not an exclusion criteria in the present study, past or current prescription medication use was present, although low, in this sample (24% on any medication) and the role of medication on EEG outcomes was not shown to differ across phenotypic groups in previous work, 15 it is unknown if EEG profiles were affected by medication use. Consideration of medication effects on EEG profiles will be important in future work, particularly given how common medication management is in this population.
Despite these limitations, findings suggest that PTSD symptom presentations can be validated using exogenous biological markers, which opens the door for investigation of relevant biologic measures that either cut across disorders or differentiate symptom presentations of PTSD. Classification of varied PTSD symptom presentations should further our understanding of the neurobiology of PTSD and better inform its treatment. 
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